Research Use Only. This product is intended as a research chemical only. Not for human or animal use.

Weight Loss

Tirzepatide

5 mg

>99% HPLC

Tirzepatide is a dual GIP and GLP-1 receptor agonist, representing a novel approach to metabolic research. It activates both incretin pathways, providing a synergistic effect on glucose homeostasis and energy balance.

Lab Result

Tirzepatide 5mg

Batch TRZ30-82

Avg. Purity

99.87%

Avg. Mass

5.51 mg

Result Date

March 1, 2026

Date Added

March 7, 2026

How it Works

In Plain Language

If Semaglutide is like pressing one 'metabolic reset button,' Tirzepatide presses two at the same time. It activates both of the body's main fullness/metabolism pathways (GIP and GLP-1), which work together to create a stronger combined effect on how the body processes sugar and regulates weight.

Pathway Overview

Administration

Receptor Binding

Pathway Activation

Biological Response

Research Applications

Dual pathway activation

Enhanced metabolic research

Glucose homeostasis

Synergistic incretin signaling